DrugPatentWatch Database Preview
Adenosine - Generic Drug Details
What are the generic drug sources for adenosine and what is the scope of adenosine patent protection?
Adenosine
is the generic ingredient in three branded drugs marketed by Astellas, Akorn, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Hospira Inc, and Mylan Asi, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-six drug master file entries for adenosine. Twenty-one suppliers are listed for this compound. There are three tentative approvals for this compound.
Summary for adenosine
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 13 |
NDAs: | 23 |
Drug Master File Entries: | 26 |
Suppliers / Packagers: | 21 |
Bulk Api Vendors: | 121 |
Clinical Trials: | 424 |
Patent Applications: | 7,230 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for adenosine |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for adenosine |
DailyMed Link: | adenosine at DailyMed |
Pharmacology for adenosine
Drug Class | Adenosine Receptor Agonist |
Mechanism of Action | Adenosine Receptor Agonists |
Medical Subject Heading (MeSH) Categories for adenosine
Synonyms for adenosine
.beta.-Adenosine |
.beta.-D-Adenosine |
.beta.-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy- |
.beta.-D-Ribofuranoside, adenine-9 |
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
[U-14C]adenosine |
1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose |
1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose |
158749-77-0 |
177030-94-3 |
1dgm |
1odi |
244769-76-4 |
2fqy |
2gl0 |
2ydo |
30143-02-3 |
3axz |
3ay0 |
3H-adenosine |
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside |
46946-45-6 |
46969-16-8 |
4cki |
4ckj |
4pd9 |
5536-17-4 |
58-61-7 |
6-Amino-9-.beta.-ribofuranosyl-9H-purine |
6-Amino-9-beta-D-ribofuranosyl-9H-purine |
6-Amino-9.beta.-D-ribofuranosyl-9H-purine |
6-Amino-9beta-D-ribofuranosyl-9H-purine |
6-Amino-9beta-delta-ribofuranosyl-9H-purine |
9- -D-Ribofuranosyladenine |
9-?-D-Ribofuranosyl-9H-purin-6-amine |
9-.alpha.-D-Arabinofuranosyladenine |
9-.beta.-D-Ribofuranosidoadenine |
9-.beta.-D-Ribofuranosyl-9H-purin-6-amine |
9-.beta.-d-Ribofuranosyladenine |
9-(beta-D-Arabinofuranosyl)adenine |
9-beta-D-Ribofuranosidoadenine |
9-beta-D-Ribofuranosyl-9H-purin-6-amine |
9-beta-D-Ribofuranosyladenine |
9-beta-delta-Arabinofuranosyladenine |
9-beta-delta-Ribofuranosidoadenine |
9-beta-delta-Ribofuranosyl-9H-purin-6-amine |
9-beta-delta-Ribofuranosyladenine |
9beta-D-ribofuranosyl-9H-Purin-6-amine |
9beta-D-Ribofuranosyladenine |
9beta-delta-ribofuranosyl-9H-Purin-6-amine |
9beta-delta-Ribofuranosyladenine |
9H-Purin-6-amine, 9-.beta.-d-ribofuranosyl- |
9H-Purin-6-amine, 9beta-D-ribofuranosyl- |
A0152 |
AB0012292 |
AB00384349_13 |
AB00384349_14 |
AB00384349-11 |
AC-27494 |
AC-8229 |
AC1L1U8O |
AC1Q1ID3 |
AC1Q52XU |
ACT02616 |
Ade-Rib |
Adenin riboside |
Adenine 9-beta-D-arabinofuranoside |
Adenine nucleoside |
Adenine riboside |
Adenine riboside, Adenine-9-beta-D-ribofuranoside |
Adenine-9- -D-ribofuranoside |
Adenine-9-beta-D-ribofuranoside |
adenine-9beta-D-Ribofuranoside |
adenine-9beta-delta-Ribofuranoside |
adenine-D-ribose |
Adenocard |
Adenocard (TN) |
Adenocard, Adenosine |
Adenocor |
Adenoscan |
Adenoscan (TN) |
Adenosin |
Adenosin [German] |
Adenosina |
Adenosine (Adenocard) |
Adenosine (JAN/USP) |
Adenosine [USAN:BAN] |
Adenosine [USAN:USP:BAN] |
adenosine-2-13C-N,1,3-15N3 |
adenosine-8-13C |
adenosine-9-15N |
adenosine-N-15N |
Adenosine, >=99% |
Adenosine, European Pharmacopoeia (EP) Reference Standard |
Adenosine, homopolymer |
Adenosine, pharmaceutical secondary standard; traceable to USP and PhEur |
Adenosine, suitable for cell culture, BioReagent |
Adenosine, United States Pharmacopeia (USP) Reference Standard |
Adenosine, Vetec(TM) reagent grade, 98% |
Adenosinum |
Adensoine |
AI3-52413 |
AJ-34020 |
AK-77288 |
AKOS015888594 |
alpha-Adenosine |
AM83931 |
ANW-32994 |
Arabinosyl-adenine |
AS-12664 |
AT-11502 |
b-D-Adenosine |
BB_NC-0565 |
BDBM14487 |
beta-Adenosine |
beta-D-Adenosine |
beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy- |
beta-D-Ribofuranoside, adenine-9 |
beta-delta-Adenosine |
Bio1_000437 |
Bio1_000926 |
Bio1_001415 |
bmse000061 |
bmse000996 |
Boniton |
BR-77288 |
BSPBio_001796 |
BT000369 |
C00212 |
CAS-58-61-7 |
Caswell No. 010B |
CCG-38824 |
CCRIS 2557 |
CHEBI:16335 |
CHEMBL477 |
cid_191 |
cid_60961 |
CJ-07924 |
CTK1G9587 |
D-Adenosine |
D00045 |
D06IAR |
DB-022408 |
DB00640 |
DSSTox_CID_2558 |
DSSTox_GSID_22558 |
DSSTox_RID_76628 |
DTXSID1022558 |
EA6C60C2-6AFB-4264-A2F0-541373DB950E |
EINECS 200-389-9 |
Epitope ID:140947 |
Formycin A, from Streptomyces kaniharaensis, >=98% (HPLC) |
FT-0082881 |
FT-0620931 |
GTPL2844 |
HMS1920A13 |
HMS2091G13 |
HMS2235E24 |
HSDB 7774 |
K72T3FS567 |
KB-47159 |
KBio3_001296 |
KS-0000010G |
KSC269K8P |
LS-15085 |
MCULE-7071766082 |
MEDR-640 |
MFCD00005752 |
MFCD00065471 |
MLS000069638 |
MLS002153227 |
MLS006010946 |
MolPort-001-838-229 |
Myocol |
N6-Methylado |
NCGC00023673-03 |
NCGC00023673-04 |
NCGC00023673-05 |
NCGC00023673-06 |
NCGC00023673-07 |
NCGC00178869-03 |
NSC 627048 |
NSC 7652 |
NSC-755857 |
NSC627048 |
NSC755857 |
NSC7652 |
NU001462 |
NU007624 |
NU007625 |
NU008403 |
Nucleocardyl |
OIRDTQYFTABQOQ-KQYNXXCUSA-N |
Pallacor |
Pharmakon1600-01500107 |
Polyadenosine |
Polyriboadenosine |
PubChem9306 |
REGID_for_CID_60961 |
Riboadenosine |
RP29522 |
RP29523 |
RTR-020367 |
S-3476 |
s1647 |
Sandesin |
SBI-0206673.P002 |
SCHEMBL731 |
SDCCGMLS-0003108.P003 |
SMR000058216 |
SPBio_001194 |
SPECTRUM1500107 |
Spectrum2_001257 |
Spectrum3_000288 |
SR 96225 |
SR-05000001981 |
SR-05000001981-2 |
SR-96225 |
ST009496 |
ST2407911 |
SUN-Y4001 |
TL8003749 |
Tox21_110891 |
Tox21_110891_1 |
TR-020367 |
UNII-K72T3FS567 |
USAF CB-10 |
Z1741978458 |
ZINC2169830 |
US Patents and Regulatory Information for adenosine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Asi | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 090212-002 | Mar 28, 2014 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Luitpold | ADENOSINE | adenosine | INJECTABLE;INJECTION | 090010-001 | Apr 28, 2009 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Fresenius Kabi Usa | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 077897-001 | Nov 27, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Gland Pharma Ltd | ADENOSINE | adenosine | INJECTABLE;INJECTION | 077283-001 | Jun 14, 2007 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Fresenius Kabi Usa | ADENOSINE | adenosine | INJECTABLE;INJECTION | 205568-001 | Apr 16, 2018 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
West-ward Pharms Int | ADENOSINE | adenosine | INJECTABLE;INJECTION | 076500-001 | Jun 16, 2004 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for adenosine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-002 | May 18, 1995 | ➤ Sign Up | ➤ Sign Up |
Astellas | ADENOCARD | adenosine | INJECTABLE;INJECTION | 019937-002 | Oct 30, 1989 | ➤ Sign Up | ➤ Sign Up |
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-001 | May 18, 1995 | ➤ Sign Up | ➤ Sign Up |
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-001 | May 18, 1995 | ➤ Sign Up | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:









Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.